Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2016; 115(03): 682-684
DOI: 10.1160/th15-08-0683
DOI: 10.1160/th15-08-0683
Letters to the Editor
The association of F11 genetic variants with the risk of incident venous thrombosis among women, by statin use
Financial support: This study was supported by the National Heart, Lung, and Blood Institute (NHLBI) Cardiovascular Disease Training Grant (HL007902, David S. Siscovick) as well as grants HL043201 (B. M. Psaty), HL060739 (B. M. Psaty), HL068986 (S. R. Heckbert), HL073410 (N. L. Smith), HL074745 (B. M. Psaty), HL085251 (B. M. Psaty), HL095080, and HL121414 (N. L. Smith) from the NHLBI.Further Information
Publication History
Received:
26 August 2015
Accepted after minor revision:
29 October 2015
Publication Date:
20 March 2018 (online)
Supplementary Material to this article is available online at www.thrombosis-online.com.
-
References
- 1 Smith NL, Hindorff LA, Heckbert SR. et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. J Am Med Assoc 2007; 297: 489-498.
- 2 Bezemer ID, Bare LA, Doggen CJ. et al. Gene variants associated with deep vein thrombosis. J Am Med Assoc 2008; 299: 1306-1314.
- 3 Li Y, Bezemer ID, Rowland CM. et al. Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost 2009; 7: 1802-1808.
- 4 Ray JG, Mamdani M, Tsuyuki RT. et al. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001; 161: 1405-1410.
- 5 Doggen CJ, Lemaitre RN, Smith NL. et al. HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost 2004; 2: 700-701.
- 6 Glynn RJ, Danielson E, Fonseca FA. et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009; 360: 1851-1861.
- 7 Bare LA, Arellano AR, Tong CH. et al. Genetic variants of F11, statin use and venous thrombosis. J Thromb Haemost 2011; 9: 1249-1251.
- 8 Smith NL, Heckbert SR, Lemaitre RN. et al. Esteri-fied estrogens and conjugated equine estrogens and the risk of venous thrombosis. J Am Med Assoc 2004; 292: 1581-1587.
- 9 Abecasis GR, Auton A, Brooks LD. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
- 10 Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol 2012; 41: 514-520.
- 11 VanderWeele T, MJ K. A tutorial on interaction. Epidemiologic Methods 2014; 3: 33-72.